Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Ophthalmology. 2022 Jul 12;129(12):1344–1356. doi: 10.1016/j.ophtha.2022.07.003

Table 5.

Intraocular Pressure and Medical Therapy at Baseline and Follow-up in the PTVT Study

Tube Group Trabeculectomy Group P-value*
Baseline
 IOP (mmHg) 23.3 ± 4.9 23.9 ± 5.7 0.35
 Glaucoma medications 3.1 ± 1.1 3.2 ± 1.1 0.56
 N 125 117

1 year
 IOP (mmHg) 13.8 ± 4.1 12.4 ± 4.4 0.012
 Glaucoma medications 2.1 ± 1.4 0.9 ± 1.4 < 0.001
 N 108 105

18 months
 IOP (mmHg) 13.5 ± 4.1 12.8 ± 4.7 0.33
 Glaucoma medications 2.1 ± 1.3 0.8 ± 1.3 < 0.001
 N 99 97

2 years
 IOP (mmHg) 13.6 ± 3.9 12.9 ± 5.2 0.28
 Glaucoma medications 2.2 ± 1.0 1.0 ± 1.5 < 0.001
 N 99 96

3 years
 IOP (mmHg) 13.9 ± 4.2 12.1 ± 4.8 0.010
 Glaucoma medications 2.1 ± 1.4 1.2 ± 1.5 < 0.001
 N 87 88

4 years
 IOP (mmHg) 13.5 ± 3.5 13.5 ± 5.4 0.98
 Glaucoma medications 2.3 ± 1.4 1.3 ± 1.4 < 0.001
 N 83 79

5 years
 IOP (mmHg) 13.4 ± 3.5 13.0 ± 5.2 0.52
 Glaucoma medications 2.2 ± 1.3 1.3 ± 1.4 < 0.001
 N 74 75

IOP = intraocular pressure

Data are presented as mean ± standard deviation

Data censored after a reoperation for glaucoma

*

Student t-test